SSRIs most commonly cause nausea, sexual dysfunction, and insomnia in the first few weeks — most GI effects improve as the body adjusts, but sexual side effects often persist throughout treatment. All SSRIs carry an FDA black box warning for increased suicidal thinking in patients under age 25, particularly during the first weeks of therapy.
SSRI Side Effects: Common, Serious & Long-Term
Selective serotonin reuptake inhibitors (SSRIs) are the most widely prescribed class of antidepressants, used to treat major depressive disorder, anxiety disorders, OCD, PTSD, and several other conditions. Common SSRIs include sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), and citalopram (Celexa).
While SSRIs are generally well tolerated relative to older antidepressants, they carry a range of side effects that can significantly affect quality of life. Understanding why these effects occur and who is most at risk helps patients and caregivers make informed decisions in partnership with their prescribers.
How SSRIs Work — and Why Side Effects Occur
SSRIs block the reuptake transporter (SERT) that normally removes serotonin from the synaptic cleft after it is released. By keeping serotonin available longer between nerve cells, SSRIs gradually enhance serotonergic neurotransmission throughout the brain. However, serotonin receptors exist throughout the entire body — not just in the brain regions involved in mood — which is why SSRIs produce effects well beyond their intended psychiatric targets.
Serotonin receptors in the gut wall explain gastrointestinal side effects. Serotonin's role in sexual function explains libido and orgasm changes. Its involvement in sleep regulation explains early insomnia or drowsiness. These are pharmacological consequences of the mechanism itself, not signs that something has gone wrong.
Common Side Effects
These effects are reported frequently, particularly during the first 2–4 weeks of treatment:
- Nausea — Serotonin receptors (5-HT3) in the gut and brainstem trigger nausea when stimulated; taking the medication with food substantially reduces this effect in most patients.
- Sexual dysfunction — Elevated serotonin suppresses dopamine pathways involved in sexual desire and inhibits spinal reflexes needed for orgasm; affects an estimated 40–65% of SSRI users and often persists throughout treatment.
- Insomnia or drowsiness — Serotonin modulates sleep architecture; some patients experience activation and insomnia (more common with fluoxetine), while others feel sedated (more common with paroxetine).
- Headache — Serotonin affects cerebrovascular tone; headaches are common in the first 1–2 weeks and typically resolve spontaneously.
- Dry mouth — Anticholinergic-adjacent effects, especially with paroxetine, reduce salivary secretion.
- Diarrhea or loose stools — Increased serotonin activity in the enteric nervous system accelerates GI motility.
- Weight changes — Weight gain (more common with paroxetine) or mild weight loss can occur; the mechanism involves serotonin's effects on appetite regulation and metabolic rate.
- Sweating — Serotonin modulates hypothalamic temperature regulation; excessive sweating, particularly at night, is a common complaint.
- Tremor or jitteriness — Especially early in treatment; reflects excess serotonergic stimulation of motor pathways.
Serious and Rare Side Effects
⚠ The following effects are uncommon but potentially life-threatening. Seek emergency care immediately if you or someone you know develops symptoms of serotonin syndrome, significant mood changes, or signs of abnormal heart rhythm.
Serotonin Syndrome
Serotonin syndrome occurs when serotonergic activity in the nervous system becomes dangerously elevated, most often when SSRIs are combined with other serotonergic drugs. Symptoms include agitation, restlessness, rapid heart rate, elevated blood pressure, dilated pupils, muscle twitching or clonus, diarrhea, and sweating. Severe cases involve high fever, muscle rigidity, seizures, and can be fatal. The most dangerous combinations are SSRIs with MAO inhibitors — this combination is contraindicated and requires a mandatory washout period.
Suicidality — FDA Black Box Warning
All antidepressants carry an FDA black box warning: clinical trials found increased rates of suicidal thinking and behavior in children, adolescents, and young adults (under 25) during the first weeks of treatment. The proposed mechanism involves initial activation or agitation before the antidepressant effect takes hold. Monitoring for worsening mood, new agitation, panic attacks, or suicidal ideation is essential in the first 4 weeks and after any dose change.
Hyponatremia (Low Sodium)
SSRIs can cause the syndrome of inappropriate antidiuretic hormone secretion (SIADH), leading to dangerously low blood sodium. Elderly patients and those on diuretics are most at risk. Symptoms include headache, confusion, nausea, and in severe cases, seizures and coma.
QT Prolongation (Citalopram)
Citalopram specifically prolongs the QT interval on the electrocardiogram in a dose-dependent manner, which can predispose to serious cardiac arrhythmias (torsades de pointes). The FDA issued a safety communication limiting maximum citalopram use and advising caution in patients with pre-existing heart conditions or those taking other QT-prolonging drugs.
Bleeding Risk
SSRIs impair platelet aggregation by depleting serotonin stored in platelets. This modestly increases the risk of bleeding, particularly GI bleeding when combined with NSAIDs, aspirin, or anticoagulants.
Long-Term Effects
Patients who take SSRIs for extended periods (months to years) may experience effects that differ from early-treatment side effects:
- Emotional blunting — Many long-term users describe a narrowing of emotional range — reduced capacity for both sadness and joy. This reflects downregulation of serotonin receptors over time and is often described as feeling emotionally "flat" or "numbed."
- Persistent sexual dysfunction — Unlike nausea, sexual side effects rarely resolve with continued use. Some patients report that sexual dysfunction persists even after discontinuing the SSRI (Post-SSRI Sexual Dysfunction, or PSSD), though this is not yet well characterized in the literature.
- Weight gain — Gradual weight gain is more likely with long-term use, particularly with paroxetine. The mechanism likely involves serotonin's effects on appetite and metabolic adaptations.
- Discontinuation syndrome — SSRIs are not physically addictive in the classical sense, but abrupt stopping (especially paroxetine and venlafaxine) can cause dizziness, electric shock sensations ("brain zaps"), nausea, irritability, and flu-like symptoms. Gradual tapering under medical guidance is recommended.
Who Is Most at Risk
- Children, adolescents, and young adults (under 25) — Heightened risk of suicidal ideation per FDA black box warning; requires close monitoring in initial weeks.
- Elderly patients — Greater susceptibility to hyponatremia, falls from dizziness, and drug interactions; SSRIs appear on the Beers Criteria for medications requiring caution in older adults.
- Patients with cardiac disease — Particularly relevant for citalopram due to QT prolongation risk.
- Patients on multiple serotonergic drugs — Tramadol, triptans, linezolid, dextromethorphan, St. John's Wort, and MAOIs all increase serotonin syndrome risk when combined with SSRIs.
- Patients on anticoagulants or NSAIDs — Additive bleeding risk from SSRI-induced platelet dysfunction.
- Patients with hyponatremia risk factors — Elderly, female sex, low body weight, thiazide diuretics, and low-sodium diet all increase SIADH risk.
Managing Side Effects
Most SSRI side effects can be reduced with practical strategies. Always discuss any changes with your prescriber — do not adjust or stop your medication without medical guidance.
- Nausea — Take with food or in the evening; the effect usually diminishes within 1–2 weeks.
- Insomnia — Take activating SSRIs (fluoxetine, sertraline) in the morning; sedating ones (paroxetine) in the evening.
- Sexual dysfunction — Discuss with your prescriber; options include switching agents, adding a non-serotonergic antidepressant, or taking medication holidays (only under medical supervision).
- Dry mouth — Stay well hydrated, use sugar-free gum or lozenges, and practice good dental hygiene to prevent cavities.
- Sweating — Breathable fabrics, cool environments; some prescribers use low-dose cyproheptadine or benztropine for severe cases.
- Discontinuation — Never stop abruptly; work with your prescriber on a slow taper plan, especially with paroxetine.
- Monitor mood changes — Keep a simple daily mood log during the first month; alert your prescriber immediately if you notice worsening depression, agitation, or new suicidal thoughts.
Frequently Asked Questions
What are the most common side effects of SSRIs?
The most common SSRI side effects are nausea (especially in the first 1–2 weeks), sexual dysfunction (reduced libido, delayed orgasm, or erectile dysfunction), insomnia or drowsiness, headache, dry mouth, and weight changes. Most initial GI side effects improve within the first few weeks as the body adjusts, but sexual side effects often persist throughout treatment.
What is serotonin syndrome and how do I recognize it?
Serotonin syndrome is a potentially life-threatening condition caused by excess serotonin activity in the nervous system. Warning signs include agitation or restlessness, rapid heart rate, high blood pressure, dilated pupils, muscle twitching or rigidity, sweating, diarrhea, and in severe cases, high fever and seizures. It most commonly occurs when SSRIs are combined with other serotonergic drugs such as MAOIs, tramadol, linezolid, or triptans. Seek emergency care immediately if you suspect serotonin syndrome.
Do SSRI side effects go away over time?
Many initial SSRI side effects — particularly nausea, headache, and sleep disturbances — tend to improve within 2–4 weeks as the body adapts. However, sexual side effects (reduced libido, delayed orgasm) and weight changes often persist or worsen throughout the course of treatment. Emotional blunting, described as a feeling of emotional flatness, is also reported as a longer-term effect by some patients.
Why do SSRIs carry a black box warning for suicidality?
The FDA requires a black box warning on all antidepressants, including SSRIs, because clinical trials found an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (under age 25) during the first few weeks of treatment. This does not mean SSRIs cause suicide — rather, they may initially increase agitation or anxiety before the antidepressant effect sets in. Patients and caregivers should monitor for worsening mood, agitation, or new suicidal thoughts, particularly in the first 4 weeks and after dose changes.
Related Drugs in This Class
⚠ This article is for informational purposes only and does not constitute medical advice. Never start, stop, or change your medication without consulting your prescriber. If you are experiencing a mental health crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911.